In addition to the chemokine receptors predominantly expressed on CD56brightCD16– NK cells, we found high expression of CXCR2 on peripheral blood CD56dimCD16+ NK cells both in healthy controls and COVID-19 patients (Figures S2A, B). The gene discussed is CXCR2; the disease is COVID-19.